跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
顺尔宁 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Montelukast Sodium Oral Granules
Approved
化学药品
Montelukast Sodium Oral Granules
ORGANON LIMITED LIABILITY COMPANY
🇨🇳 National Medical Products Administration
Approval Date
Feb 6, 2024
Approval ID
8Xx2hSl9mjd
Company
ORGANON LIMITED LIABILITY COMPANY
Type
化学药品
Approval Details
Approval Id
8Xx2hSl9mjd
Approval Number
国药准字HJ20150431
Generic Name
孟鲁司特钠颗粒
Generic Name En
Montelukast Sodium Oral Granules
Trade Name
顺尔宁
Drug Type
化学药品
Dosage Form
颗粒剂
Strength
4mg(以孟鲁司特计)
Reg Date
2024-02-06
Expired Date
2029-02-05
Company Name
ORGANON LIMITED LIABILITY COMPANY
Production Company Name
Patheon Manufacturing Services LLC
Company Detail Path
/organization/organon-limited-liability-company
Production Company Detail Path
/organization/patheon-manufacturing-services-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 6, 2024
Approval ID
8Xx2hSl9mjd
Type
化学药品
Back to NMPA Approvals